![Gabor Veres](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gabor Veres is Vice President of Research and Development for Applied Genetic Technologies Corp.
Before joining AGTC, he worked with Novartis/Systemix, CellGenesys and Sangamo Biosciences.
Dr. Veres has 15 years of experience in research and development.
He received a PhD in Biochemistry and Genetics from the University of Szeged.
| Companies | Position | End |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | - |
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services | Health Technology |
University of Szeged
 University of Szeged Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions
